Pages that link to "Item:Q2297830"
From MaRDI portal
The following pages link to Understanding the role of phenotypic switching in cancer drug resistance (Q2297830):
Displaying 10 items.
- Spatio-genetic and phenotypic modelling elucidates resistance and re-sensitisation to treatment in heterogeneous melanoma (Q1739290) (← links)
- Transition therapy: tackling the ecology of tumor phenotypic plasticity (Q2070285) (← links)
- Phase-specific cancer-immune model considering acquired resistance to therapeutic agents (Q2661016) (← links)
- A continuation technique for maximum likelihood estimators in biological models (Q6077310) (← links)
- A comparison of mutation and amplification-driven resistance mechanisms and their impacts on tumor recurrence (Q6080346) (← links)
- Statistical inference of the rates of cell proliferation and phenotypic switching in cancer (Q6174231) (← links)
- Cell population growth kinetics in the presence of stochastic heterogeneity of cell phenotype (Q6192800) (← links)
- Mathematical modeling and dynamic analysis for cancer resistance incorporating persister cells (Q6543572) (← links)
- A stochastic population model for the impact of cancer cell dormancy on therapy success (Q6671218) (← links)
- Optimisation of gene expression noise for cellular persistence against lethal events (Q6671224) (← links)